EN | UA
EN | UA

Help Support

Back

Effect of combined oral contraceptive in endometriosis people with or without adenomyosis

adenomyosis adenomyosis
adenomyosis adenomyosis

A prospective, observational study was carried out to determine the influence of combined oral contraceptives (COC) in overall and sexual quality of life post-treatment in endometriosis and adenomyosis (AD) plus endometriosis people.

See All

Key take away

Combined oral contraceptive regimen improves sexual and overall quality of life post-treatment in deep infiltrating endometriosis patients with or without adenomyosis.

Background

A prospective, observational study was carried out to determine the influence of combined oral contraceptives (COC) in overall and sexual quality of life post-treatment in endometriosis and adenomyosis (AD) plus endometriosis people.

Method

Notably, 42 females suffering from deep infiltrating endometriosis (DIE), 31 suffering from DIE plus AD and 39 non-AD/DIE controls were enrolled. All the subjects were examined for the pain symptoms (dysuria, dyschezia, dyspareunia and dysmenorrhea). Following parameters were evaluated: (a) heavy menstrual bleeding using the Pictorial Blood Loss Assessment Chart, (b) quality of life of patients via Short Form-36 questionnaire (SF-36), (c) sexual quality of life using Brief Profile of Female Sexual Function (B-PFSF) and Sexual Quality of Life-Female questionnaire (SQOL-F).

Result

At baseline, higher scores in SF-36, SQOL-F and B-PFSF questionnaires were observed in non AD/DIE controls when compared to other groups. The higher intensity in pain symptoms and deteriorated quality of sexual life was reported in DIE plus AD subjects compared with DIE subjects.

A remarkable improvement was observed in sexual and overall quality of life in DIE and DIE plus AD groups following 12 months of treatment with enhancement in sexual quality of life being slightly higher in DIE plus AD subjects in comparison to DIE subjects. A decrease in the pain symptoms was also noted in both groups.

Conclusion

COC containing 2 mg dienogest/30 μg ethinyl estradiol may improve overall and sexual quality of life post-treatment in DIE and DIE plus AD patients, but further studies are required to confirm these findings.

Source:

The Journal of Sexual Medicine

Article:

Assessment of Quality of Life, Sexual Quality of Life, and Pain Symptoms in Deep Infiltrating Endometriosis Patients With or Without Associated Adenomyosis and the Influence of a Flexible Extended Combined Oral Contraceptive Regimen: Results of a Prospective, Observational Study

Authors:

Ana María Alcalde et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: